Skip to main content
Figure 3 | Breast Cancer Research

Figure 3

From: Penta-O-galloyl-β-D-glucose induces G1arrest and DNA replicative S-phase arrest independently of P21 cyclin-dependent kinase inhibitor 1A, P27 cyclin-dependent kinase inhibitor 1B and P53 in human breast cancer cells and is orally active against triple-negative xenograft growth

Figure 3

Effect of PGG on cyclin D1, P21Cip1, and P27Kip1 and other select cell cycle proteins in MCF-7 and MDA-MB231 cells detected by Western blot analyses. (a) Cyclin D1, CDK4, P21Cip1, and P27Kip1 expression and P53-Ser15P in MCF-7 cells. β-Actin was re-probed as loading control. (b) P21Cip1 and P27Kip1 expression in MDA-MB231 cells. (c) Time course of cyclin D1 expression in MCF-7 and MDA-MB231 cells treated with PGG from 12 to 48 hours. Patterns are representative of two experiments. The medium was not changed for PGG exposure of longer than 24 hours. P21Cip1, cyclin-dependent kinase inhibitor 1A; P27Kip1, cyclin-dependent kinase inhibitor 1B; PGG, penta-O-galloyl-β-D-glucose.

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us